HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luigi Bennardo Selected Research

Cicatrix (Scar)

1/2024New Insight into Nonablative 675-nm Laser Technology: Current Applications and Future Perspectives.
11/2023An Innovative Dual-Wavelength Laser Technique for Atrophic Acne Scar Management: A Pilot Study.
10/2023Laser Impacts on Skin Rejuvenation: The Use of a Synergistic Emission of CO2 and 1540 nm Wavelengths.
9/2022Fractional Q-Switched 1064 nm Laser for Treatment of Atrophic Scars in Asian Skin.
1/2022Sequential Use of CO2 Laser Prior to Nd:YAG and Dye Laser in the Management of Non-Facial Warts: A Retrospective Study.
1/2022Combined CO2 and dye laser technique in the treatment of outcomes due to flap necrosis after surgery for basal cell carcinoma on the nose.
9/2021Histological Skin Changes After Treatment with 675 nm Laser.
6/2021Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip.
5/2021A giant epidermal nevus of the face treated with a CO2 and dye laser combination: a case report and literature review.
2/2021A new 675-nm laser device in the treatment of acne scars: an observational study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luigi Bennardo Research Topics

Disease

10Cicatrix (Scar)
01/2024 - 02/2021
7Psoriasis (Pustulosis Palmaris et Plantaris)
12/2023 - 11/2018
5Acne Vulgaris
01/2024 - 10/2018
3Melanoma (Melanoma, Malignant)
12/2023 - 04/2021
3Hypopigmentation (Hypomelanosis)
11/2023 - 02/2021
3Erythema
10/2023 - 02/2021
3Pain (Aches)
09/2022 - 09/2020
3Atopic Dermatitis (Atopic Eczema)
01/2022 - 11/2018
3COVID-19
11/2021 - 05/2021
3Hyperpigmentation
09/2021 - 02/2021
2Skin Diseases (Skin Disease)
04/2024 - 01/2022
2Delayed Hypersensitivity (Hypersensitivity, Type IV)
04/2024 - 02/2022
2Melanosis (Freckles)
01/2024 - 09/2020
2Skin Neoplasms (Skin Cancer)
12/2023 - 12/2021
2Basal Cell Carcinoma (Rodent Ulcer)
12/2023 - 01/2022
2Inflammation (Inflammations)
05/2022 - 01/2019
2Pruritus (Itching)
05/2022 - 01/2020
2Infections
01/2022 - 05/2021
2Alopecia (Baldness)
10/2021 - 10/2018
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2021 - 01/2021
1Allergic Contact Dermatitis
04/2024
1Neoplasms (Cancer)
12/2023
1Telangiectasis (Telangiectasia)
05/2022
1Stroke (Strokes)
05/2022
1Prurigo
05/2022
1Striae Distensae
03/2022
1Drug-Related Side Effects and Adverse Reactions
02/2022
1Cellulite
01/2022
1Warts (Wart)
01/2022
1Hidrocystoma
01/2022
1Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2022
1Neurofibroma
01/2022
1Necrosis
01/2022
1Actinic Keratosis
12/2021
1Chronic Urticaria
11/2021
1Epidermal Nevus
05/2021
1Chronic Kidney Failure (Chronic Renal Failure)
05/2021
1Cutaneous Leishmaniasis
05/2021
1Hemangioma (Angioma)
03/2021
1Purpura
03/2021
1Nevus of Ota
02/2021
1Corneal Injuries
02/2021
1Lichen Sclerosus et Atrophicus (Lichen Sclerosus)
01/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Hidradenitis Suppurativa
11/2020
1Erectile Dysfunction
01/2020
1Osteonecrosis (Kienbock's Disease)
01/2020

Drug/Important Bio-Agent (IBA)

21-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2023 - 01/2021
2secukinumabIBA
12/2023 - 01/2020
2dupilumabIBA
05/2022 - 01/2022
2ixekizumabIBA
05/2021 - 01/2020
2InterleukinsIBA
11/2020 - 11/2020
1AllergensIBA
04/2024
1CollagenIBA
01/2024
1Prostaglandins AIBA
10/2023
1yttrium-aluminum-garnetIBA
09/2022
1NeodymiumIBA
09/2022
1mRNA VaccinesIBA
02/2022
1VaccinesIBA
02/2022
1Excipients (Suspending Agents)IBA
02/2022
1ColchicineFDA LinkGeneric
01/2022
1AlkaloidsIBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1ChromiumIBA
12/2021
1Heavy MetalsIBA
12/2021
1ArsenicIBA
12/2021
1Omalizumab (Xolair)FDA Link
11/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
08/2021
1Imiquimod (Aldara)FDA LinkGeneric
06/2021
1RifamycinsIBA
05/2021
1Cyclin-Dependent Kinase 4IBA
01/2021
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2021
1ribociclibIBA
01/2021
1AcidsIBA
01/2021
1Hormones (Hormone)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1palbociclibIBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1SteroidsIBA
01/2021
1abemaciclibIBA
01/2021
1CytokinesIBA
11/2020
1Interleukin-23 (Interleukin 23)IBA
11/2020
1risankizumabIBA
11/2020
1betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
01/2020
1Insulin (Novolin)FDA Link
01/2020
1Histamine Antagonists (Antihistamines)IBA
01/2020

Therapy/Procedure

14Lasers (Laser)
01/2024 - 09/2020
13Therapeutics
12/2023 - 10/2018
10Gas Lasers
12/2023 - 01/2020
5Dye Lasers
01/2022 - 03/2021
3Solid-State Lasers
09/2022 - 01/2022
2Photochemotherapy (Photodynamic Therapy)
12/2023 - 01/2021
2Drug Therapy (Chemotherapy)
01/2021 - 01/2020
1Rejuvenation
10/2023
1Hair Removal (Depilation)
09/2022
1Operative Surgical Procedures
01/2022
1Phototherapy (Light Therapy)
10/2021
1Aftercare (After-Treatment)
05/2021
1Adjuvant Radiotherapy
04/2021
1Injections
01/2020